Buspirone
- Generic Name
- Buspirone
- Brand Names
- Buspar
- Drug Type
- Small Molecule
- Chemical Formula
- C21H31N5O2
- CAS Number
- 36505-84-7
- Unique Ingredient Identifier
- TK65WKS8HL
- Background
Buspirone is a novel anxiolytic agent with a unique structure and a pharmacological profile. Belonging to the azaspirodecanedione drug class, buspirone is a serotonin 5-HT receptor agonist that is not chemically or pharmacologically related to benzodiazepines, barbiturates, and other sedative/anxiolytic drugs. Unlike many drugs used to treat anxiety, buspiro...
- Indication
Indicated for the management of anxiety disorders or the short-term relief of the symptoms of anxiety.
- Associated Conditions
- Anxiety Disorders, Depression
- Associated Therapies
- -
Anxiety Disorders and Depression Treatment Market to Reach
The Anxiety Disorders and Depression Treatment Market was valued at USD 12.2 billion in 2023 and is projected to reach USD 16.65 billion by 2032, growing at a CAGR of 3.53%. This growth is driven by the rising prevalence of anxiety disorders and depression, advancements in pharmaceutical therapies, and increased awareness and destigmatization of mental health issues.
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath